Best Life Sciences Platforms and Tools Companies in France
The 312 best Life Sciences Platforms and Tools companies in France in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: DNA Script.
France's Life Sciences Platforms and Tools sector is what this directory maps — 312 companies, $1.1B in disclosed funding, ranked by equity raised and recent momentum.
Afyren leads at $97M, which is a long way ahead of Phagos at $32M and SeqOne at $26M. No unicorns yet, but the funding base is real and the investor roster, Europa, EIC Fund, Bpifrance, Kreaxi, Aquiti Gestion, reads like a who's who of European deep-tech capital. So what's pulling the money in? The global market for life sciences platforms and tools sat at roughly $89.4B in 2020 and is forecast to reach $183.8B by 2027, a 10.8% CAGR according to Precedence Research, driven by advances in quantitative accuracy, mass spectrometry resolution and information sciences. That tailwind is structural, not cyclical, and France is positioned squarely inside it.
I'd flag one thing you won't see in the headline numbers: regulatory friction is real here, and it shapes how fast these platforms can move from bench to market. The gap between Afyren's raise and the rest of the pack suggests capital is concentrating in a handful of proven platforms while earlier-stage companies work harder for smaller rounds. Spore Biotechnologies at $9M, CTIBiotech at $1M, these aren't failures, they're a reminder that the middle of this market is still forming.
- ResearchAndMarkets.com
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in France
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | DNA Script Developer of benchtop DNA printer for nucleic acid synthesis | $315M | 33 mo ago | 202 | 2014 | Xavier Godron Co-founder & CTO | Top 10M | 334 patents Enzymatic, template‑free nucleic acid synthesis and purification for custom DNA manufacturing | — |
| 2 | HiFiBiO Provider of a technology platform for the discovery of antibody-based drugs | $180M | 60 mo ago | 75 | 2013 | Liang Schweizer Founder | — | 36 patents Ligand‑receptor pair identification and biosensor assay technologies for drug discovery | — |
| 3 | AFYREN Provider of analytical services for microbiology, chemistry and bioprocesses industries 40Funding top 25%Talent top 28%Moat top 35%Patents top 37% All 11 signals ▾Fundingtop 25% Talenttop 28% Moattop 35% Patentstop 37% Techtop 43% Innovationtop 48% Growthtop 48% Newsbottom 49% Globalbottom 40% Marketbottom 32% Fin. healthbottom 20% Funding: Raised $96.9M across 7 rounds · 7 rounds over 11 yrs (0.6/yr) Talent: 3 named leaders on record · 3 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 40/100 | $97M | 1 mo ago | 32 | 2012 | Regis Nouaille Co-Founder | Top 5M | 118 patents Recovery and valorization of potassium salts and metabolites from anaerobic fermentation processes | — |
| 4 | Stilla Technologies Developer of digital PCR solution for research | $53M | 54 mo ago | 100 | 2013 | Clement Gay Co-Founder | Top 10M | — | — |
| 5 | Mablink Provider of Antibody-Drug-Conjugates (ADC's) technology for cancer treatment | $35M | 44 mo ago | 29 | 2018 | Charles Dumontet Co-Founder | — | — | — |
| 6 | Phagos Developer of AI-powered bioplatform for targeted bacterial treatments using phages 64Funding top 34%AI top 35%Global top 45%Talent top 45% All 5 signals ▾Fundingtop 34% AItop 35% Globaltop 45% Talenttop 45% Techbottom 45% Funding: Raised $31.6M across 2 rounds · 2 rounds over 1 yrs (2.0/yr) AI: Product described with: ai-powered, artificial intelligence rank vs industry peers · Fliar Intelligence Index 64/100 | $32M | 8 mo ago | — | 2021 | Adèle James Co-Founder & CTO | Top 50M | — | 1 award |
| 7 | Fermentalg Innovating with algae for sustainable solutions in nutrition and environmental impact | $30M | 53 mo ago | 62 | 2005 | — | Top 5M | 387 patents Microalgal biotech producing DHA oils, pigments, glycogen-derived products, and cosmetic extracts | 1 launch |
| 8 | SeqOne Provider of bioinformatics tools for the analysis of genome sequencing data 55Growth top 32%Moat top 37%Funding top 38%Patents top 44% All 10 signals ▾Growthtop 32% Moattop 37% Fundingtop 38% Patentstop 44% Innovationtop 47% Techtop 48% Markettop 50% Talentbottom 49% Globalbottom 36% Newsbottom 20% Growth: Web rank 10,000,000 → 5,000,000 YoY · 1 acquisition/expansion move in 24 mo Moat: Editorial + unicorn rating 6/10 · IP moat: 18 patents rank vs industry peers · Fliar Intelligence Index 55/100 | $26M | 12 mo ago | 70 | 2017 | Nicolas Philippe CEO | Top 5M | 18 patents Bioinformatics platforms for genomic HRD detection, structural variant identification, and phenotyping support | 1 partnership |
| 9 | Qubit Pharmaceuticals Developer of drugs for the treatment of cancer and inflammatory diseases | $25M | 45 mo ago | 50 | 2020 | Jay Ponder Co-Founder | Top 50M | 15 patents Quantum algorithms for molecular simulation and optimized quantum circuit design for chemistry | 2 partnerships |
| 10 | Metafora Biosystems Provider of diagnostic tests and reagents for research | $23M | 41 mo ago | 32 | 2011 | Luc Dauriol Co-Founder & Chairman | — | 37 patents Diagnostic biomarkers and computational tools for single‑cell analysis in hematology | — |
| 11 | Astraveus Provider of a device for autologous cell and gene therapies | $18M | 17 mo ago | 29 | 2016 | Jeremie Laurent Founder & CEO | Top 10M | 51 patents Parallel microfluidic bioprocessing platforms for high‑throughput cell and particle handling | — |
| 12 | Cytoo Specializes in the development of physiologically-relevant cellular models and assays for High Content… | $16M | 174 mo ago | 36 | 2008 | Jacques Lewiner Co-Founder | Top 50M | 39 patents Therapeutics and AI-driven assays for skeletal muscle hypertrophy and disease diagnostics | — |
| 13 | Core Biogenesis Provider of UBaaS platform for recombinant protein bioproduction | $14M | 50 mo ago | 39 | 2020 | Chouaib Meziadi CSO | — | 9 patents Patents concentrated in chemistry & materials | — |
| 14 | Meiogenix Developer of novel breeding technologies for crop plants | $13M | 54 mo ago | 7 | 2010 | Luc Mathis CEO | Top 50M | 39 patents CRISPR-driven meiotic recombination tools for precise plant breeding and genetics | — |
| 15 | GenOway Provider of transgenic rodent models and customized cell lines for preclinical development | $12M | 77 mo ago | 124 | 1999 | — | Top 5M | 15 patents Genetically engineered animal models with conditional KO/KI and advanced cloning vectors | 1 partnership |
| 16 | Flash Therapeutics Provider of gene-based therapeutics for multiple disorders | $12M | 59 mo ago | 49 | 2005 | — | — | 37 patents Apelin-based lymphedema therapy and viral RNA/genome‑editing delivery platforms | — |
| 17 | Okomera Developer of a device for in vitro cancer testing using a microfluidic chip | $11M | 29 mo ago | 15 | 2020 | Aimee Wessel Co-Founder & CEO | Top 50M | 2 patents Microfluidic droplet generation and collection devices for precise fluid handling | — |
| 18 | Aenitis Developer of acoustic based tools for cell sorting | $10M | 60 mo ago | 13 | 2014 | Emmanuel VINCENT Co-Founder & CEO | — | — | — |
| 19 | Plant Advanced Technologies Plant biotechnology company producing rare actives for cosmetic, pharmaceutical, agrochemical markets | $10M | 61 mo ago | 59 | 2005 | — | Top 50M | 64 patents Botanical root extracts and bioactive compounds for cosmetics, pharmaceuticals, and affinity assays | — |
| 20 | Indatech Offering mass spectroscopy for early-stage development | $9M | 65 mo ago | 15 | 2009 | Chauchard Fabien Co-Founder | — | 22 patents Raman immersion probes for spectroscopic analysis of particle clusters and material inhomogeneities | 1 launch |
| 21 | Poietis Laser-assisted 3D bioprinting technology | $9M | 45 mo ago | 38 | 2014 | — | Top 50M | 65 patents Laser-based 3D bioprinting of living tissues and cellular constructs | — |
| 22 | NETRI Developer of microfluidic devices for industrial applications | $9M | 16 mo ago | 45 | 2018 | Florian Larramendy CEO - CTO - Co-founder | Top 10M | 33 patents Microfluidic cell‑culture platforms integrating humidification and large‑scale neural activity assays | 2 partnerships |
| 23 | Spore Biotechnologies Developer of microbial detection technology for life science industries 53AI top 15%Growth top 35%Talent top 38%Funding top 42% All 10 signals ▾AItop 15% Growthtop 35% Talenttop 38% Fundingtop 42% Moattop 42% Techtop 43% Patentstop 46% Innovationbottom 47% Globalbottom 39% Marketbottom 23% AI: Holds AI/ML patents (G06N-family CPC) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 53/100 | $9M | 5 mo ago | 5 | 2022 | Amine Raji Co-Founder & CEO | Top 10M | 7 patents Rapid bacterial detection and analysis using spectroscopic and AI-driven diagnostic devices | 1 job opening · 1 award |
| 24 | Igyxos Developer of antibodies for the treatment of infertility | $9M | 86 mo ago | 10 | 2017 | Marie-Christine Maurel Founder | Top 50M | 21 patents Humanized antibodies and ligands enhancing gonadotropin hormone therapeutics for fertility | — |
| 25 | ProteoGenix Provider of custom synthesis and analytical services | $8M | 194 mo ago | 7 | 2003 | Philippe Funfrock CEO | Top 5M | — | — |
| 26 | Scipio Bioscience Develops sample preparation solutions | $8M | 36 mo ago | 44 | 2017 | Pierre Walrafen Co-Founder & CEO | — | 19 patents Hydrogel-based spatial omics platforms for single-cell capture and barcoding | — |
| 27 | 3-D Matrix Developer of synthetic peptides for medical applications | $6M | 18 mo ago | 37 | 2004 | — | Top 10M | 23 patents Patents concentrated in health & consumer products | — |
| 28 | Feeligreen Trans-dermal micro-current based drug delivery devices for dermatology | $5M | 108 mo ago | 9 | 2012 | — | Top 5M | 111 patents Dermatological and cosmetic skin treatment devices for therapeutic and aesthetic applications. | — |
| 29 | Polyplus Transfection Transfection Solutions for Healthcare and Life Sciences organizations | $5M | 185 mo ago | 139 | 2001 | — | — | 119 patents Non‑viral nucleic acid delivery reagents and purification methods for gene/mRNA transfection | — |
| 30 | One Biosciences Developer of single-cell therapeutics solutions to treat multiple health disorders | $5M | 11 mo ago | — | 2020 | Celine Vallot Co-Founder | Top 10M | — | 1 partnership · 1 expansion · 2 awards |
| 31 | Glycode Technology platform for producing recombinant therapeutic glycoproteins | $4M | 197 mo ago | — | 2004 | Christophe Javaud CEO | — | 20 patents Yeast-based recombinant glycoengineering for homogeneous therapeutic glycoprotein production | — |
| 32 | Fluigent Manufacturer of microfluidic flow control systems and associated lab equipment | $4M | 91 mo ago | 54 | 2005 | — | Top 5M | 61 patents Microfluidic pressure and flow regulation devices for lab‑on‑a‑chip fluid handling | — |
| 33 | Novacyt A molecular diagnostics company specializing in genomic medicine solutions | $4M | 96 mo ago | 222 | 2005 | — | Top 10M | 133 patents Automated sample prep and digital cytology/histology analysis for cellular diagnostics | — |
| 34 | Elveflow Developer of flow control systems | $4M | 55 mo ago | 45 | 2011 | Eric Farin CEO | Top 5M | — | 1 partnership |
| 35 | Altar Developer of fluidic automated systems for the continuous culture of microbial suspensions | $3M | 65 mo ago | 18 | 2017 | — | — | 6 patents Continuous adaptive evolution of living cells via sustained bioreactor culture | — |
| 36 | Cheryl Biotech Temperature control platform for cell biology research | $3M | 49 mo ago | 17 | 2014 | — | Top 10M | — | — |
| 37 | Syndivia Developer of antibody drug conjugates for cancer treatment | $3M | 75 mo ago | 5 | 2014 | Sergii Kolodych Co-founder & CSO | — | 31 patents Site-specific antibody-drug conjugates for targeted delivery of cytotoxic agents in oncology | — |
| 38 | Inorevia Developer of microfluidics platform | $3M | 48 mo ago | 16 | 2016 | Laurent Malaquin Co-Founder | — | 8 patents Microfluidic droplet manipulation, sorting, and individual droplet extraction technologies. | — |
| 39 | LXRepair Provider of multiplexed assays for determination of the enzymatic status of cellular DNA repair | $3M | 85 mo ago | 7 | 2013 | Sylvie Sauvaigo Founder & CEO | — | 7 patents DNA repair profiling assays for tumor radiosensitivity and toxicity prediction | — |
| 40 | ScreenCell Developer of circulating tumor cells | $3M | 113 mo ago | 11 | 2011 | — | — | 32 patents Microfluidic biomarker assays for circulating tumor cell detection and sickle‑cell diagnostics | — |
| 41 | Eden Tech Provider of microfabrication solutions for bioinspired microfluidics technologies | $2M | 54 mo ago | — | 2017 | Emmanuel Roy Co-Founder & CEO | Top 10M | — | 1 launch |
| 42 | Abbelight Provider of solutions for microscopes, reagents, and software for image analysis 57AI top 15%Product top 30%Moat top 32%Innovation top 40% All 9 signals ▾AItop 15% Producttop 30% Moattop 32% Innovationtop 40% Patentstop 40% Fundingtop 42% Techbottom 48% Marketbottom 42% Globalbottom 36% AI: Holds AI/ML patents (G06N-family CPC) Product: 4 distinct product lines · Company stage: Series B rank vs industry peers · Fliar Intelligence Index 57/100 | $2M | 5 mo ago | 42 | 2015 | — | Top 10M | 24 patents Super-resolution single-molecule fluorescence microscopy hardware and image data handling | 2 awards |
| 43 | Omini Developer of point-of-care lab-on-chip devices for immediate blood tests | $2M | 64 mo ago | 29 | 2019 | — | — | — | 2 internships · 1 award |
| 44 | Minos Biosciences Developer of a sequencing-based multi-omic analysis device | $2M | 62 mo ago | 11 | 2020 | Hubert Geisler Co-founder & Head of Microfluidics | — | — | — |
| 45 | Carroucell Provider of microcarrier for cell culture in a bioreactor | $1M | 45 mo ago | 6 | 2016 | Takis Breyiannis CEO | — | 14 patents Magnetic and microcarrier scaffolds for scalable cell culture and bioprocessing | — |
| 46 | CTIBiotech Develops 3D human tissue models 19Tech top 45%Talent bottom 49%Funding bottom 47%Global bottom 29% All 5 signals ▾Techtop 45% Talentbottom 49% Fundingbottom 47% Globalbottom 29% Marketbottom 25% Tech: 17 technologies across 5/8 capability areas · Cloud: Amazon Ses, Amazon Web Services Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 19/100 | $1M | 1 mo ago | — | 2009 | Nico Forraz CEO | Top 50M | — | 2 launchs · 1 partnership · 1 award |
| 47 | EVerZom Developer of a technology platform for the production of extracellular vesicles | $1M | 12 mo ago | 17 | 2018 | Max Piffoux Co-Founder & CTO | Top 10M | — | — |
| 48 | Smartox Biotechnology Discovery and the synthesis of peptides coming from animal venoms and related drug discovery services | $1M | 32 mo ago | 14 | 2009 | Michel De Waard Founder | Top 50M | — | — |
| 49 | Glowee Provider of bioluminescent lighting solutions | $678K | 36 mo ago | 25 | 2014 | Sandra Rey Founder & CEO | Top 50M | 10 patents Engineered bioluminescent proteins and bacterial systems for sustainable lighting of façades and decorative panels. | — |
| 50 | Kolibri Developer of acoustic wave-based bioreactors to handle mammalian cells | $250K | 33 mo ago | 11 | 2020 | Gabriel dumy Co-Founder | — | 3 patents Acoustic microfluidic cell culture platforms for compartmentalized tissue engineering | — |
Top 12 Life Sciences Platforms and Tools companies in France
#1
Public · Paris, Ile de France · founded 2012 · 32 employees$96.9Mraised▾
Provider of analytical services for microbiology, chemistry, and bioprocesses industries. It has developed its product known as Afynerie, technology, which directly valorizes non-food biomass (wastes) into biomolecules of high energetical and chemical interest. The company offers services including the measurement of methane volume (or more generally biogas) produced by degradation of organic substrates by anaerobic microorganisms, & organic substrates physicochemical characterization.
- Apr 2026Grant (prize money)$3.5M
- Feb 2026Post IPO$8.2M
- Nov 2025Post IPO$26.6M
- Jul 2025Grant (prize money)$4.7M
#2
Series A · Suresnes, Ile de France · founded 2021$31.6Mraised▾
Developer of AI-powered bioplatform for targeted bacterial treatments using phages. The platform combines microbiology and artificial intelligence to design treatments using phages. Treatments are continuously updated to ensure subjects stay healthy. The solution is being deployed across chicken, cattle, swine, and shrimp sectors.
- Oct 2025Series A$29.2M
- Sep 2025Seed$2.4M
#3
Series A · Paris, Ile de France · founded 2022 · 5 employees$8.6Mraised▾
Developer of microbial detection technology for life science industries. The company is developing innovative technologies to detect bacterial and microbial risk for various industries food&beverage, cosmetics, and pharmaceutics manufacturers.
- Jan 2026Grant (prize money)—
- Feb 2025Series A$23M
- Dec 2023Seed$8.6M
#4
Funding Raised · Lyon, Auvergne Rhone Alpes · founded 2009$1.5Mraised▾
CTIBiotech is a developer of 3D human tissue models for the pharmaceutical industry and dermato-cosmetics sectors. The company also claims of printing cancer tissues in 3D using the tools in bioengineering. It offers 3D tissue and cell models to the pharmaceutical industry for cancer research, regenerative medicine, medical devices, public and private research institutions, and organizations. Offers human biological sample procurement & cell harvesting.
- Apr 2026Grant (prize money)$1.5M
#5
Series A · Montpellier, Occitanie · founded 2017 · 70 employees$26.1Mraised▾
Provider of bioinformatics tools for the analysis of genome sequencing data. The platform helps researchers to detect & identify the variants responsible for gene mutation. It helps to detect many types of variants such as SNPs, Indels, CNVs, and mid-sized deletions.
- May 2025Series A$22.7M
- Jan 2022Series A$22.7M
- Mar 2019Series A$3.4M
#6
Series B · Paris, Ile de France · founded 2015 · 42 employees$2.1Mraised▾
Abbelight provides microscopes, reagents, and software for image analysis. Their 3D fluorescence nanoscopy products include Single Molecule Localization Microscopy (SMLM), high-throughput 2D single-molecule and TIRF imaging, and 3D single-molecule and multi-color imaging. The company also offers smart kits and reagents (dyes) for research use and software that allows the production and manipulation of 3D quantitative data.
- Jan 2026Series B—
- Jul 2023Grant (prize money)$600.7K
- Apr 2022Grant (prize money)$52.7K
- May 2020Grant (prize money)$1.3M
#7
Seed · Paris, Ile de France · founded 2016 · 29 employees$18Mraised▾
Provider of a device for autologous cell and gene therapies. The company focuses on building high-tech equipment to manufacture autologous cell and gene therapies which include CAR-T or stem cell treatments. The company has developed Lakhesys a microfluidic technology to develop cellular therapies for various disease conditions.
- Dec 2024Grant (prize money)$7.4M
- Oct 2023Grant (prize money)$1.1M
- Jun 2023Seed$18M
- Feb 2022Grant (prize money)$56.3K
#8
Series A · Paris, Ile de France · founded 2020$5Mraised▾
Developer of single-cell therapeutics solutions to treat multiple health disorders. The company's proprietary platform uses single-cell RNA and DNA sequencing that helps to analyze disease-causing agents and provides treatment solutions. The company has developed single-cell computational software for the analysis of genomic data.
- Jul 2025Series A$17.4M
- Sep 2022Series A$5M
#9
Series C · Paris, Ile de France · founded 2014 · 202 employees$315Mraised▾
DNA script is a developer of a benchtop DNA printer powered by enzymatic technology for nucleic acid syntheis. It is offering a benchtop DNA printer that provides outsourced chemical-based DNA synthesis through enzymatic synthesis technology to synthesize DNA.
- Sep 2023Grant (prize money)$4.3M
- Jan 2022Series C$35M
- Oct 2021Series C$165M
- Sep 2021Grant (prize money)$280K
#10
Series A · Lyon, Auvergne Rhone Alpes · founded 2018 · 45 employees$8.9Mraised▾
Developer of microfluidic devices for industrial applications. The company has NeoBento a microfluidic platform that focuses on the development of next-generation 3D brain-on-a-chip models for the treatment of neurological diseases.
- Feb 2025Series A$5.1M
- Mar 2022Series A$8.9M
#11
Seed · Paris, Ile de France · founded 2018 · 17 employees$1.3Mraised▾
EVerZom develops a technology platform for the production of extracellular vesicles. The extracellular vesicles are generated by Mesenchymal stem cells having regenerative properties. This method can be used to apply turbulence stimulation to cells.
- Jun 2025Grant (prize money)$3.5M
- Jun 2022Grant (prize money)$118.7K
- May 2022Grant (prize money)$1.8M
- Nov 2021Grant (prize money)$3.4M
#12
Public · Caluire et Cuire, Auvergne Rhone Alpes · founded 2004 · 37 employees$5.9Mraised▾
3-D Matrix develops synthetic peptides for medical applications. The company synthesizes the self-assembling peptide matrix which is composed of three amino acids in a sequence that is repeated 4 times (Arginine - Alanine - Aspartic Acid - Alanine). The company's product includes PuraStat, a self-assembling synthetic peptide scaffold that mimics the human extra cellular matrix (ECM). The product is used in endoscopic, cardiac, and ENT solutions.
- Nov 2024Post IPO$5.7M
- Jan 2021Grant (prize money)$231.9K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics is moving in France
A read on the academic research around Bioinformatics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,937 France-affiliated papers.
- Centre National de la Recherche Scientifique581
- Inserm393
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement130
- Assistance Publique – Hôpitaux de Paris112
- European Molecular Biology Laboratory87
- Genome15→94
- Gene20→91
- Transcriptome2→53
- Chromatin2→28
- Identification (biology)2→27
- Gene4→56
- Transcriptome3→39
- Genome5→24
- Biomarker1→17
- In silico1→16
- Disease3→34
- Gene1→19
- Cancer2→17
- Clinical trial2→16
- Immune system2→14
Where bioinformatics is researched across France
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing bioinformatics patents in France
France bioinformatics patent filing is steady — 2 filings from 4 assignees (2024–2025), led by UNIV Paris CITE, Centre NAT RECH Scient, Ecole NAT Superieure DE Chimie P; annual filings 1→1.
- UNIV Paris CITE2
- Centre NAT RECH Scient2
- Ecole NAT Superieure DE Chimie P1
- Ecole NAT Superieure DE Chimie D1
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.